Pancreas getting a major software update! 🔬 Stem cell treatment helped 10/12 severe Type 1 diabetes patients ditch insulin therapy after a year. The lab-grown islet cells are apparently better at self-regulation than most of us are. Still in phase 3 trials, but promising!
https://science.slashdot.org/story/25/06/25/026238/stem-cell-treatment-may-cure-severe-type-1-diabetes-study-finds
#StemCells #Diabetes #VertexPharmaceuticals
Stem Cell Treatment May Cure Severe Type 1 Diabetes, Study Finds - Slashdot
A groundbreaking stem cell treatment developed by Vertex Pharmaceuticals has allowed 10 out of 12 patients with severe type 1 diabetes to stop insulin therapy after one year. While the trial included some side effects and two unrelated deaths, the results mark a major step forward and have progresse...
Vertex Pharmaceuticals' stem cell breakthrough: 10 severe diabetics freed from insulin dependency! The catch? Lifelong immunosuppressants required to protect the new pancreatic cells. Still, trading multiple daily insulin shots for pills feels like meaningful progress. 🧬
https://science.slashdot.org/story/25/06/22/0317248/people-with-severe-type-1-diabetes-are-cured-in-small-trial-of-new-drug
#VertexPharmaceuticals #Diabetes #StemCells
People with Severe Type 1 Diabetes are Cured in Small Trial of New Drug - Slashdot
"A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of Type 1 diabetes," reports the New York Times.
"One year later, these 10 patients no longer need insulin. The other two patients need much lower doses."
The experimental treatment, cal...
Vertex Pharmaceuticals Stock Rebounds on Better-Than-Expected Earnings and Guidance
Vertex Pharmaceuticals stock rebounds as Q4 earnings exceed expectations and 2025 revenue guidance surpasses market forecasts, despite slight EPS miss
As Vertex preps for exa-cel launch, exec touts 'very large' opportunity but tempers early expectations-- Sen. Bernie Sanders moves toward another hearing with pharma CEOs --Eisai expects Alzheimer's drug to rake in revenue of $66.5 million by March -- See more on our front page news
http://bit.ly/w28kSd #vertexpharmaceuticals #genetherapy #senate #drugpricing #pharmaceos #berniesanders #eisai #alzheimers #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Cafepharma
Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.
'Caught in the middle': A battle between Vertex and insurers is leaving cystic fibrosis patients with crushing drug costs
“These companies — the drug company and the insurer — like to point fingers at each other, but it’s not right to put the burden on the patient."
Loki the Cat
Yonhap Infomax News
cafepharma
Spotlight
Joyce Bell 🇺🇦🇨🇦🇲🇽🇬🇱🚫🧊